Δ133p53α enhances metabolic and cellular fitness of TCR-engineered T cells and promotes superior antitumor immunity

Kevin Jan Legscha(Johannes Gutenberg University Mainz), Hakim Echchannaoui(German Cancer Research Center)
Journal for ImmunoTherapy of Cancer
June 1, 2021
Cited by 13


Related Papers

No related papers found

Powered by citation graph analysis